Selbyville, Delaware, Sept. 14, 2020 (GLOBE NEWSWIRE) —
According to latest report “Bioreactors Market by Product Type (Single-use, Reusable), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), End-use (R&D Organizations, Biopharma Manufacturers, CMOs), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026”, by Global Market Insights, Inc., the market valuation of bioreactors will cross $12 billion by 2026. Increasing emphasis on drug development will increase the demand for bioreactors over the coming years.
COVID-19 pandemic has affected millions of people, thereby escalating the demand for vaccines for better medical treatment. There is massive surge in the usage of bioreactors in pharmaceutical and biotechnology industry for large production. Thus, the World Health Organization (WHO) has recommended fast vaccine production for all the patients in severe and critical condition to reduce the mortality rate, escalating the adoption rate of bioreactors.
Request for a sample of this research report @
Technological advancements in bioreactors related to design, material and processing will fuel the bioreactors market revenue. Innovations in bioreactors contribute to improvement in the biological processes. These advancements include continuous manufacturing, process analytical technology, and single-use systems. Single-use bioreactors have been used widely for commercial biomanufacturing facilities. They offer reduced contamination, multiple biologics production and same floor space to manufacture different products. Moreover, favorable government regulations and addressing customer needs by manufacturing units will offer immense growth to the market.
Reusable bioreactor segment is estimated to witness around 15.6% growth rate through 2026 owing to large production ability, cost efficiency and flexibility. Additionally, rising chronic conditions and increasing demand for vaccine and other biological products, the usage of reusable bioreactors will grow in near future.
The yeast cells segment held over 4% bioreactors market share in 2019. Apart from usage of yeast cells in the food industry, its usage has been widely accepted in the healthcare industry. Use of probiotics has been beneficial on a large scale for the treatment of various disorders such as intestinal and immunomodulatory effects. In addition, function of yeast for the bioavailability of minerals, folate biofortification and mycotoxins detoxification will further propel the market expansion.
Monoclonal antibodies (mAb) segment in the bioreactors market will exhibit significant growth during the forecast period led by growing burden of disorders such as asthma, cancer, rheumatoid arthritis, and inflammatory diseases. Furthermore, use of monoclonal antibodies for therapeutic treatment has augmented its large-scale production.
Outsourcing to contract manufacturing organizations (CMOs) particularly in the biopharmaceuticals sector is anticipated to boost the segment growth till 2026. Contract manufacturing organizations reduce cost burden of manufacturing and therefore in high demand. Companies from the U.S. and Europe are establishing operations in the emerging countries such as India, South Korea, China, and Singapore.
Europe bioreactors market accounted for more than 37% revenue share in 2019. Growing awareness, larger patient pool suffering from chronic disorders and better healthcare spending capacity will positively impact the market demand. Also, presence of established players influences its availability and adoption of bioreactors in the region. Moreover, rising number of COVID-19 patients, in the region will augment the European market demand =.
Request for customization of this research report @
A few notable companies operating in the bioreactors market include Thermo Fisher Scientific, GE Healthcare, Merck Group, and Sartorius Stedim Biotech Group among other players. Market players are focusing expanding their industry footprint by adopting several inorganic strategies such as product launch, acquisitions, and marketing campaigns to expand business growth opportunities.
Table of Contents (ToC) of the report:
Chapter 3. Bioreactors Market Insights
3.1. Industry segmentation
3.2. Industry landscape, 2015 – 2026 (USD Million)
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.2. Industry pitfalls and challenges
3.4. Growth potential analysis
3.4.1. By product type
3.4.2. By cell trends
3.4.3. By molecule
3.4.4. By End-use
3.5. COVID-19 impact analysis
3.6. Technology landscape
3.6.1. Technology overview of single-use bioreactors
188.8.131.52. Wave-induced motion SUB
184.108.40.206. Single-use Bubble Column
220.127.116.11. Stirred SUB
3.7. Porter’s analysis
3.8. Competitive landscape, 2019
3.9. PESTEL analysis
Browse Complete Table of Contents (ToC) @
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: [email protected]